NCT02725242

Efficacy of Once-daily Budesonide/Formoterol Turbuhaler 4.5/160 µg in Step Down Asthma

A 12-week, Randomized, Parallel-group, Phase III Study Comparing the Efficacy of Once-daily Budesonide/Formoterol Turbuhaler (160/4.5 μg/d) and Twice-daily Budesonide Giona Easyhaler (400 μg/d) During Step-down Period in Well Controlled Asthma

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 77 (actual)
• Sponsor: Hat Yai Medical Education Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate the efficacy of Once-daily Budesonide/formoterol Turbuhaler 160/4.5 µg/d in the period of step down in well controlled asthmatic patient.

Detailed description

The study will measure the efficacy of once daily low dose ICS/ LABA in well controlled asthmatic patient comparing with low dose ICS in step down circumstance.

Conditions

• Asthma

Interventions

Type	Name	Description
DRUG	Budesonide/formoterol (160/4.5 μg/d)	After the patients who have all criteria, they will be randomization to take Budesonide/formoterol (160/4.5 μg/d)
DRUG	Budesonide (400μg/d)	After the patients who have all criteria, they will be randomization to take Budesonide (200 ug) twice daily

Timeline

• Start date: 2016-03-01
• Primary completion: 2016-12-01
• Completion: 2016-12-01
• First posted: 2016-03-31
• Last updated: 2017-04-18

Locations

1 site across 1 country: Thailand